AZD3427, a relaxin mimetic in pulmonary hypertension group 2 associated with left heart disease: design and rationale of the phase 2b Re-PHIRE Study
13 May 2024 (12:00 - 13:00)
Organised by: 
About the speaker
Medical University of Warsaw, Warsaw (Poland)
5 More presentations in this session
Assistant Professor A. Lacraru (Bucharest, RO)
Professor A. Safarova (Baku, AZ)
Doctor A. Ferreira (Lisbon, PT)
Doctor P. Tolomeo (Glasgow, GB)
Access the full session
The Event
Heart Failure 2024
13 May 2024
12:00 CET
You may be interested in
Congress Presentation
Congress Session
